WVP
PFE icon

Worth Venture Partners’s Pfizer PFE Stock Holding History

Worth Venture Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-28,900
Closed -$17.1K – 64
2024
Q2 		$17.1K Buy
+28,900
New +$796K 0.13% 53
2023
Q1 		– Sell
-44,800
Closed -$4.1K – 212
2022
Q4 		$4.1K Buy
+44,800
New +$2.15M ﹤0.01% 166

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Worth Venture Partners's PFE Position: Q3 2024 in Review

Worth Venture Partners sold out of Pfizer (PFE) in Q3 2024, closing a stake of 29,100 shares — an estimated $814K sold.

Worth Venture Partners first reported a position in PFE in Q1 2023 and held it in 2 quarters. The position peaked at $1.05M in Q1 2023. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Worth Venture Partners reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • Worth Venture Partners sold 29,100 Pfizer shares in Q3 2024, an estimated $814K.
  • Worth Venture Partners first reported a position in Pfizer in Q1 2023 and held it in 2 quarters.
  • Worth Venture Partners's Pfizer position peaked at $1.05M in Q1 2023.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Worth Venture Partners's 13F filing for Q3 2024, filed 14 Nov 2024.